Cost-effectiveness analysis of pembrolizumab plus chemotherapy for previously untreated metastatic non-small cell lung cancer in the USA
Zeng, Xiaohui, Wan, Xiaomin, Peng, Liubao, Peng, Ye, Ma, Fang, Liu, Qiao, Tan, ChongqingVolume:
9
Journal:
BMJ Open
DOI:
10.1136/bmjopen-2019-031019
Date:
December, 2019
File:
PDF, 397 KB
2019